Bone Metastases in Men With Hormone-Refractory Prostate Cancer

3 clinical trials · Condition

Record	Firm	Date
Open-Label Access Protocol of Denosumab for Subjects With Advanced Cancer (NCT01419717)	Amgen	2011-11-22
Open Label Extension to SRE Studies in United Kingdom and Czech Republic Only (NCT00950911)	Amgen	2009-07-01
Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates (NCT00104650)	Amgen	2005-01-01

Every clearance here is in the API, with alerts when new ones post.